Analogue simulation technology platform for whole process of drug research and development
By designing a simulation technology platform with modules such as medical molecular collision subsystems, the problem of complex operation and maintenance difficulties of drug research and development simulation experimental system is solved, and the effect of simplification of operation and high utilization is achieved, providing convenient drug research and development Auxiliary tools.
Patent Information
- Application Number
- CN202310654597.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-05
- Publication Date
- 2024-12-06
AI Technical Summary
The existing drug research and development simulation experimental system has complex operating steps and difficulty in maintaining faults, which affects the utilization rate of simulation experiments.
A simulation technology platform including a medical molecular collision subsystem, a deployment subsystem, an experimental information module, a drug molecule operation module, an experimental log module and a drug molecule type module was designed to simplify the operation process and allow some parameters to be manually adjusted, which is convenient. Drug simulation experiment.
It has achieved simplification of operation of drug simulation experiments, shortened operation time, improved utilization rate and maintenance convenience of simulation experiments, and provided more efficient auxiliary tools for drug research and development.
Smart Images

Figure CN119092149A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of drug development simulation technology, and in particular to a simulation technology platform for the entire drug development process. Background Art
[0002] The progress and development of society have laid the foundation for improving people's quality of life. And high-quality life is nothing more than having a healthy body. However, environmental pollution, life pressure, and various negative influences have led to the emergence of various diseases, and sub-health status has become an important problem that troubles modern people. The emergence of various new diseases and health problems requires scientific researchers to devote themselves to the research and development of drugs, so that they can continuously develop and develop drugs to maintain people's health, thereby ensuring the improvement of people's quality of life. Drug research and development is an industry with high cost, long cycle, high risk and high return rate. The existing drug research and development requires a lot of research and data collection in the early stage, and the best mid- and late-stage research and development plans and market applications. In addition, a lot of experiments and accumulation of a lot of data are required during the development process.
[0003] For example, the patent with publication number CN115394375A discloses an AI technology platform for the entire process of drug research and development, a big data information database for storing data, the big data information database has an AI chip; an information entry unit with several terminals, a medicine management unit, and a medical feedback unit for collecting medical effect data information; the AI chip is used to virtually create and analyze drug molecules through artificial intelligence technology based on natural language processing and deep learning, and to virtually create through AI technology, combine drug molecules in various forms, and analyze drug molecules, directly providing a large amount of experimental data information, saving research and development costs, shortening the drug research and development cycle, and improving the success rate of drug research and development.
[0004] The existing drug development simulation experiment system has relatively complicated operation steps. Once a failure occurs, it is troublesome to maintain, which affects the utilization rate of the simulation experiment. Therefore, a simulation technology platform for the entire process of drug development is proposed to solve the above problems. Summary of the invention
[0005] 1. Technical issues to be resolved
[0006] In view of the deficiencies of the prior art, the present invention provides a simulation technology platform for the entire process of drug research and development.
[0007] (II) Technical solution
[0008] To achieve the above-mentioned purpose, the present invention provides the following technical solutions: a simulation technology platform for the entire process of drug research and development, including a simulation system, wherein the simulation system includes a drug molecule collision subsystem, a deployment subsystem, an experimental information module, a drug molecule operation module, an experimental log module and a drug molecule type module.
[0009] The pharmaceutical molecule collision subsystem includes a fluid property module, a geometric tool module, a boundary setting module, a calculation setting module, an image data module and a data display module.
[0010] The deployment subsystem includes a reset image module, a reset calculation module, a single-step calculation module, a start operation module and an operation data saving module.
[0011] Preferably, the fluid property module includes a resolution module, a flow rate module and a kinematic viscosity module, and the geometric tool module includes a rectangle module, a straight line module, an arc module and a circle module.
[0012] Preferably, the boundary setting module includes an entry setting module and an exit setting module, and the calculation setting module includes a contrast module, an animation collision module, a tracking particle module, a particle density module and a particle color module.
[0013] Preferably, the resolution module is used to adjust the resolution of the fluid; the flow rate module is used to adjust the flow rate of the fluid when it moves; and the kinematic viscosity module is used to adjust the kinematic viscosity of the fluid.
[0014] Preferably, the contrast module in the calculation setting module is used to adjust the particle contrast; the animation collision module is used to adjust the particle animation collision, the particle density module is used to adjust the particle display density, and the particle color module is used to adjust the particle color.
[0015] Preferably, the reset image module in the deployment subsystem is used to reset the particle display image, the reset calculation module is used to reset the particle calculation, the single-step calculation module is used to perform single-step calculations on the movement of the particles, the start operation module is used for the system to perform test simulations on drug molecules, and the operation data saving module is used to save the operation simulation data of drug molecules.
[0016] Preferably, the experimental information module includes an experimental information main table module, an experimental version module, a medical experiment operation result module and a drug molecule library, wherein:
[0017] The experimental information main table module is used to record the drug experimental information of this drug development simulation;
[0018] The experimental version module is used to record the version information of the drug development simulation experiment;
[0019] The medical experiment operation result module is used to record the medical experiment operation result information of the drug development simulation;
[0020] The drug molecule library is a collection of entity compounds with specific structures or functions and related information under certain specific standards, and is usually used as a tool for new drug discovery or cell induction to screen drugs.
[0021] Preferably, the drug molecule operation module includes a drug target module and a drug target operation module, wherein:
[0022] The drug target module is used to display the binding site between the drug and the biological macromolecules of the body, namely the drug target;
[0023] The drug target operation module is used for combining the drug with the biological macromolecules of the body.
[0024] Preferably, the experimental log module is used to record the drug development experimental process, and the drug molecule type module is used to select the simulation experiment type of the drug molecule.
[0025] (III) Beneficial effects
[0026] Compared with the prior art, the present invention provides a simulation technology platform for the entire process of drug development, which has the following beneficial effects:
[0027] This is a simulation technology platform for the entire process of drug research and development. By establishing a simulation system technology platform based on a drug molecule collision subsystem, a deployment subsystem, an experimental information module, a drug molecule operation module, an experimental log module and a drug molecule type module, the simulation system technology platform is easy to operate, which shortens the operation time of drug simulation experiments. At the same time, some parameters of the simulation experiment can be adjusted manually, which is convenient for staff to conduct simulation experiments on drugs, providing convenience for assisting pharmaceutical companies in drug research and development. It also has the advantages of high utilization rate and easy maintenance in experimental teaching, which improves the practicality of the simulation technology platform for the entire process of drug research and development. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0029] Figure 1 It is a schematic diagram of the system framework of the present invention;
[0030] Figure 2 This is a schematic diagram of the deployment subsystem framework of the present invention;
[0031] Figure 3 It is a schematic diagram of the fluid property module of the present invention;
[0032] Figure 4 It is a schematic diagram of the geometric tool module of the present invention;
[0033] Figure 5 This is a schematic diagram of a boundary setting module of the present invention;
[0034] Figure 6 This is a schematic diagram of the calculation setting module of the present invention;
[0035] Figure 7 This is a schematic diagram of the interface of the geometry tool module of the present invention;
[0036] Figure 8 It is a schematic diagram of flow around an arc-shaped obstacle of the present invention;
[0037] Fig. 9 It is a schematic diagram of the fluid mechanics characteristics of the fixed airfoil of the present invention. DETAILED DESCRIPTION
[0038] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.
[0039] Examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limiting the present invention.
[0040] like Figure 1-9 As shown, the present invention provides a simulation technology platform for the entire process of drug research and development, including a simulation system, the simulation system includes a drug molecule collision subsystem, a deployment subsystem, an experimental information module, a drug molecule operation module, an experimental log module and a drug molecule type module.
[0041] The pharmaceutical molecule collision subsystem includes a fluid property module, a geometry tool module, a boundary setting module, a calculation setting module, an image data module and a data display module.
[0042] The deployment subsystem includes a reset image module, a reset calculation module, a single-step calculation module, a start operation module and an operation data saving module.
[0043] The fluid property module includes a resolution module, a flow velocity module and a kinematic viscosity module, and the geometry tool module includes a rectangle module, a straight line module, an arc module and a circle module.
[0044] The boundary setting module includes an entrance setting module and an exit setting module, and the calculation setting module includes a contrast module, an animation collision module, a tracking particle module, a particle density module and a particle color module.
[0045] The resolution module is used to adjust the resolution of the fluid; the flow rate module is used to adjust the flow speed of the fluid when it moves; and the kinematic viscosity module is used to adjust the kinematic viscosity of the fluid.
[0046] The contrast module in the calculation setting module is used to adjust the particle contrast; the animation collision module is used to adjust the particle animation collision, the particle density module is used to adjust the particle display density, and the particle color module is used to adjust the particle color.
[0047] The reset image module in the deployment subsystem is used to reset the particle display image, the reset calculation module is used to reset the particle calculation, the single-step calculation module is used to perform single-step calculations on the movement of particles, the start operation module is used for the system to simulate the test of drug molecules, and the operation data saving module is used to save the operation simulation data of drug molecules.
[0048] The experimental information module includes the experimental information main table module, the experimental version module, the medical experiment operation result module and the drug molecule library, among which:
[0049] The main table module of experimental information is used to record the drug experimental information of this drug development simulation;
[0050] The experiment version module is used to record the version information of the drug development simulation experiment;
[0051] The medical experiment operation result module is used to record the medical experiment operation result information of drug development simulation;
[0052] A drug molecule library is a collection of physical compounds with specific structures or functions and their related information under certain specific standards. It is usually used as a tool for new drug discovery or cell induction to screen drugs.
[0053] The drug molecule operation module includes the drug target module and the drug target operation module, among which:
[0054] The drug target module is used to display the binding site between the drug and the biological macromolecules of the body, namely the drug target;
[0055] The drug target operation module is used for the combination and operation of drugs and biological macromolecules in the body.
[0056] The experimental log module is used to record the drug development experimental process, and the drug molecule type module is used to select the simulation experiment type of the drug molecule.
[0057] In this embodiment, by establishing a simulation system technology platform based on a drug molecule collision subsystem, a deployment subsystem, an experimental information module, a drug molecule operation module, an experimental log module and a drug molecule type module, the simulation system technology platform is simple to operate, which shortens the operation time of the drug simulation experiment. At the same time, some parameters of the simulation experiment can be manually adjusted, which is convenient for staff to conduct simulation experiments on drugs, providing convenience for assisting pharmaceutical companies in their drug research and development work. It also has the advantages of high utilization and easy maintenance in experimental teaching, which improves the practicality of the simulation technology platform for the entire process of drug research and development.
[0058] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the statement "comprising a reference structure" do not exclude the existence of other identical elements in the process, method, article or device including the elements.
Claims
1. A simulation technology platform for the entire process of drug development, including a simulation system, characterized in that: The simulation system includes a drug molecule collision subsystem, a deployment subsystem, an experiment information module, a drug molecule operation module, an experiment log module and a drug molecule type module; The pharmaceutical molecule collision subsystem includes a fluid property module, a geometric tool module, a boundary setting module, a calculation setting module, an image data module and a data display module; The deployment subsystem includes a reset image module, a reset calculation module, a single-step calculation module, a start operation module and an operation data saving module.
2. A simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The fluid property module includes a resolution module, a flow rate module and a kinematic viscosity module, and the geometric tool module includes a rectangle module, a straight line module, an arc module and a circle module.
3. A simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The boundary setting module includes an entry setting module and an exit setting module, and the calculation setting module includes a contrast module, an animation collision module, a tracking particle module, a particle density module and a particle color module.
4. A simulation technology platform for the entire process of drug development according to claim 2, characterized in that: The resolution module is used to adjust the resolution of the fluid; the flow rate module is used to adjust the flow rate of the fluid when it moves; and the kinematic viscosity module is used to adjust the kinematic viscosity of the fluid.
5. The simulation technology platform for the entire process of drug development according to claim 3, characterized in that: The contrast module in the calculation setting module is used to adjust the particle contrast; the animation collision module is used to adjust the particle animation collision, the particle density module is used to adjust the particle display density, and the particle color module is used to adjust the particle color.
6. The simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The reset image module in the deployment subsystem is used to reset the particle display image, the reset calculation module is used to reset the particle calculation, the single-step calculation module is used to perform single-step calculations on the movement of the particles, the start operation module is used for the system to simulate the test of drug molecules, and the operation data saving module is used to save the operation simulation data of drug molecules.
7. The simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The experimental information module includes an experimental information main table module, an experimental version module, a medical experiment operation result module and a drug molecule library, wherein: The experimental information main table module is used to record the drug experimental information of this drug development simulation; The experimental version module is used to record the version information of the drug development simulation experiment; The medical experiment operation result module is used to record the medical experiment operation result information of the drug development simulation; The drug molecule library is a collection of entity compounds with specific structures or functions and related information under certain specific standards, and is usually used as a tool for new drug discovery or cell induction to screen drugs.
8. The simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The drug molecule operation module includes a drug target module and a drug target operation module, wherein: The drug target module is used to display the binding site between the drug and the biological macromolecules of the body, namely the drug target; The drug target operation module is used for combining the drug with the biological macromolecules of the body.
9. The simulation technology platform for the entire process of drug development according to claim 1, characterized in that: The experimental log module is used to record the drug development experimental process, and the drug molecule type module is used to select the simulation experiment type of the drug molecule.
Citation Information
Cited By
Medicinal liquor production process simulation method
CN121118399A
